VBL Therapeutics
在场
VBL Therapeutics 是一家在股票代码 VBLT (IL) 下上市的公司。
涉及VBL Therapeutics的并购和融资。
- VBL Therapeutics and Notable Labs have announced they will merge (公布2023二月24号)..
生物技术
VBL Therapeutics 拥有 2,280 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
生物技术 行业的其他推荐联系人
消息
VBL Therapeutics 的最新新闻稿
- VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting | VBL Therapeutics
- VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting | VBL Therapeutics
- VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC | VBL Therapeutics
- VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update | VBL Therapeutics
- VBL Therapeutics Announces Workforce Reduction | VBL Therapeutics
- VBL Therapeutics Announces Top-Line Data from Phase 3 OVAL Trial of Ofra-Vec in Patients with Platinum-Resistant Ovarian Cancer | VBL Therapeutics
- VBL Therapeutics to Participate in the Jefferies Healthcare Conference | VBL Therapeutics
- VBL Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update | VBL Therapeutics
- VBL Therapeutics to Report First Quarter 2022 Financial Results on May 17 | VBL Therapeutics
- VBL Therapeutics to Participate in Upcoming Scientific and Industry Conferences in May | VBL Therapeutics
- View more press releases Close
通过电子邮件
